Argon-helium cryoablation combined with bronchial artery infusion for the treatment of advanced non-small cell lung carcinoma

胡小波,曹建民,许健,卢光明,陈波
DOI: https://doi.org/10.3969/j.issn.1008-794X.2009.07.007
2009-01-01
Abstract:Objective To investigate the technique, efficacy and clinical significance of argon-helium cryoablation combined with bronchial artery infusion(BAI) for the treatment of advanced non-small cell lung carcinoma.Methods Twenty patients, who met the requirements of this study, were divided into two groups.Patients in group A, were treated with argon-helium cryoablation only, whereas those in group B were treated with argon-helium cryoablation combined with BAI.Four week after the treatment, check-up CT scan or DSA were carried out.CT value of the tumor area both before and after the procedure was measured and compared.The clinical efficacy was evaluated based on the CT value, the parameters of CT perfusion imaging, RECIST criteria and the median survival time.Breslow method was used to figure out the median survival time and to draw the survival curves.Results The coverage of spherical frozen region was over 90% in 80% patients(16 / 20).The difference was of no significance in the coverage between two groups(P > 0.05).The CT value of group A and group B was(16.73 ± 9.43) Hu and(15.29 ± 6.98) Hu, respectively, with no significant difference(P > 0.05).The blood flow(BF), blood volume(BV) and PS before the treatment were significantly different from that after the treatment in both group A and group B(P < 0.05).The difference in BV between two groups was statistically significant(P < 0.05).The therapeutic effect of group B was better than that of group A.During the follow-up period, 10 of the 20 patients died.The longest survival time was 20 months and the shortest survival time was 7 months, with the median survival time of 9 months in group A and 14 months in group B.By using Breslow method, the difference between two groups was of statistical significance(P < 0.05).The survival curves showed that the survival rate of group B was higher than that of group A.Conclusion Argon-helium cryoablation combined with BAI is a safe and effect treatment for advanced non-small cell lung carcinoma, and its clinical efficacy is better than that of using cryoablation alone.CT perfusion imaging can reflex the changes after the operation, which is very helpful in accurately evaluating the therapeutic results.
What problem does this paper attempt to address?